Skip to main content
. 2021 Jul 29;74(9):1604–1613. doi: 10.1093/cid/ciab665

Table 4.

Frequency [n (%)] of Infant Adverse Events

Event Total (N = 49) Cohort 1 (Second Trimester, n = 24) Cohort 2 (Third Trimester, n = 25)
Serious adverse eventsa 6 (12%); 95% CI: 5–25% 4 (16.7%); 95% CI: 5–37% 2 (8%); 95% CI: .1–26%
 Neonatal sepsis 4 3 1
 Hyperbilirubin 2 1 1
 Neonatal respiratory distress 1 1 0
 Premature birth (<32 weeks) 1 1 0
 Anemia of prematurity 1 1 0
 Small for gestational ageb 1 0 1
 Subgaleal hematomaa 1 0 1
Adverse birth outcomesc 8 (16%); 95% CI: 7–30% 2 (8%); 95% CI: 1–27% 6 (24%); 95% CI: 9–45%
 Premature birth (<37 weeks) 5 (10%); 95% CI: 3–22% 1 (4%); 95% CI: .01–21% 4 (16%); 95% CI: 5–36%
 Low birth weight (<2500 g) 4 (8%); 95% CI: 2–20% 1 (4%); 95% CI: .01–22% 3 (12%); 95% CI: 3–31%
 Small for gestational ageb 3 (7%); 95% CI: 4–12% 1 (5%); 95% CI: .1–24% 2 (9%); 95% CI: 1–29%
 Intrauterine growth retardation 1 (2%); 95% CI: .7–6% 0 (0%); 95% CI: 0–16% 1 (5%); 95% CI: .1–23%

Abbreviation: CI, confidence interval; ICH, International Conference on Harmonization.

aInfants could have experienced >1 of the listed events.

bThere are 6 missing classification of newborn intrauterine growth and gestational age and only 1 of the 3 was a serious adverse event (had met ICH criteria of hospitalization).

c The adverse birth outcomes reported in this table are on the live born infants only, stillbirth is reported as a maternal adverse event in Table 3.